Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus

BACKGROUND: There have been scarce data comparing cardiovascular outcomes between individual sodium-glucose cotransporter-2 (SGLT2) inhibitors. We aimed to compare the subsequent cardiovascular risk between individual SGLT2 inhibitors. METHODS: We analyzed 25,315 patients with diabetes mellitus (DM)...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Yuta, Kaneko, Hidehiro, Okada, Akira, Itoh, Hidetaka, Matsuoka, Satoshi, Fujiu, Katsuhito, Michihata, Nobuaki, Jo, Taisuke, Takeda, Norifumi, Morita, Hiroyuki, Kamiya, Kentaro, Matsunaga, Atsuhiko, Ako, Junya, Node, Koichi, Yasunaga, Hideo, Komuro, Issei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115977/
https://www.ncbi.nlm.nih.gov/pubmed/35585590
http://dx.doi.org/10.1186/s12933-022-01508-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115977/
https://www.ncbi.nlm.nih.gov/pubmed/35585590
http://dx.doi.org/10.1186/s12933-022-01508-6

Ejemplares similares